-
公开(公告)号:US11091560B2
公开(公告)日:2021-08-17
申请号:US17069760
申请日:2020-10-13
发明人: Kensuke Miyake , Yusuke Murakami , Yuji Motoi , Atsuo Kanno , Toshiyuki Shimizu , Umeharu Ohto , Takaichi Shimozato , Atsushi Manno , Takashi Kagari , Jun Ishiguro , Kensuke Nakamura , Takashi Isobe
IPC分类号: C07K16/28 , A61K39/395
摘要: The present invention provides a pharmaceutical composition comprising an antibody which binds specifically to human TLR7 or monkey TLR7 and does not bind to mouse TLR7 or rat TLR7, and has an activity of inhibiting a function of human TLR7 or monkey TLR7, and the like.
-
公开(公告)号:US20210040225A1
公开(公告)日:2021-02-11
申请号:US17069760
申请日:2020-10-13
发明人: Kensuke Miyake , Yusuke Murakami , Yuji Motoi , Atsuo Kanno , Toshiyuki Shimizu , Umeharu Ohto , Takaichi Shimozato , Atsushi Manno , Takashi Kagari , Jun Ishiguro , Kensuke Nakamura , Takashi Isobe
IPC分类号: C07K16/28
摘要: The present invention provides a pharmaceutical composition comprising an antibody which binds specifically to human TLR7 or monkey TLR7 and does not bind to mouse TLR7 or rat TLR7, and has an activity of inhibiting a function of human TLR7 or monkey TLR7, and the like.
-
公开(公告)号:US11578138B2
公开(公告)日:2023-02-14
申请号:US17366820
申请日:2021-07-02
发明人: Kensuke Miyake , Yusuke Murakami , Yuji Motoi , Atsuo Kanno , Toshiyuki Shimizu , Umeharu Ohto , Takaichi Shimozato , Atsushi Manno , Takashi Kagari , Jun Ishiguro , Kensuke Nakamura , Takashi Isobe
IPC分类号: C07K16/28
摘要: The present invention provides a pharmaceutical composition comprising an antibody which binds specifically to human TLR7 or monkey TLR7 and does not bind to mouse TLR7 or rat TLR7, and has an activity of inhibiting a function of human TLR7 or monkey TLR7, and the like.
-
公开(公告)号:US20210332149A1
公开(公告)日:2021-10-28
申请号:US17366820
申请日:2021-07-02
发明人: Kensuke Miyake , Yusuke Murakami , Yuji Motoi , Atsuo Kanno , Toshiyuki Shimizu , Umeharu Ohto , Takaichi Shimozato , Atsushi Manno , Takashi Kagari , Jun Ishiguro , Kensuke Nakamura , Takashi Isobe
IPC分类号: C07K16/28
摘要: The present invention provides a pharmaceutical composition comprising an antibody which binds specifically to human TLR7 or monkey TLR7 and does not bind to mouse TLR7 or rat TLR7, and has an activity of inhibiting a function of human TLR7 or monkey TLR7, and the like.
-
-
-